 Molecular Targeted Therapy
"Molecular Targeted Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Treatments with drugs which interact with or block synthesis of specific cellular components characteristic of the individual's disease in order to stop or interrupt the specific biochemical dysfunction involved in progression of the disease.
| Descriptor ID |
D058990
|
| MeSH Number(s) |
E02.319.574
|
| Concept/Terms |
Molecular Targeted Therapy- Molecular Targeted Therapy
- Molecular Targeted Therapies
- Targeted Therapies, Molecular
- Targeted Therapy, Molecular
- Therapies, Molecular Targeted
- Therapy, Molecular Targeted
- Targeted Molecular Therapy
- Molecular Therapies, Targeted
- Molecular Therapy, Targeted
- Targeted Molecular Therapies
- Therapies, Targeted Molecular
- Therapy, Targeted Molecular
|
Below are MeSH descriptors whose meaning is more general than "Molecular Targeted Therapy".
Below are MeSH descriptors whose meaning is more specific than "Molecular Targeted Therapy".
This graph shows the total number of publications written about "Molecular Targeted Therapy" by people in this website by year, and whether "Molecular Targeted Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 3 | 2 | 5 | | 2011 | 5 | 11 | 16 | | 2012 | 6 | 6 | 12 | | 2013 | 15 | 8 | 23 | | 2014 | 14 | 14 | 28 | | 2015 | 10 | 23 | 33 | | 2016 | 12 | 19 | 31 | | 2017 | 6 | 29 | 35 | | 2018 | 9 | 19 | 28 | | 2019 | 5 | 24 | 29 | | 2020 | 4 | 13 | 17 | | 2021 | 5 | 7 | 12 | | 2022 | 0 | 2 | 2 | | 2023 | 0 | 2 | 2 | | 2024 | 1 | 13 | 14 | | 2025 | 8 | 5 | 13 | | 2026 | 1 | 7 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Molecular Targeted Therapy" by people in Profiles.
-
Saygin C, Witkowski MT, Cetin S, Aldoss I, Luskin MR. Incorporating ALL Biology into Treatment Decisions: Next Steps toward Targeted Therapy in Adult ALL. Blood Cancer Discov. 2026 May 05; 7(3):369-379.
-
Dao D, Kozak K, Mailhot A, Tutton S, Rutkowski P, Wilky BA. Desmoid Tumors-Biology-Driven Management and Treatment Selection. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e520026.
-
Riely GJ, Wood DE, Aisner DL, Axtell AL, Bauman JR, Bharat A, Chang JY, Desai A, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Juloori A, Lackner RP, Lanuti M, Levy B, Lin J, Loo BW, Lovly CM, Maldonado F, Morgensztern D, Mullikin TC, Ng T, Owen D, Owen DH, Patil T, Polanco PM, Riess J, Mendez ALR, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yau E, Yun K, Gregory K, Hang L. Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2026 Apr; 24(4).
-
da Silva RA, Parween S, Howell A, Gil CD, Vergara MN. Formyl peptide receptors as therapeutic targets in eye disease. Trends Pharmacol Sci. 2026 Apr; 47(4):351-354.
-
Rosas R, Baracaldo-Lancheros LF, Dykhuizen EC, Musselman CA. Structural landscape of H3K27me3 recognition by protein domains and their potential for inhibition. J Biol Chem. 2026 Apr; 302(4):111344.
-
Shah NJ, Sura S, Shinde R, Dai W, Wentworth C, Conkling P, Bupathi M, Vickery D, Perini R, Motzer RJ. Real-world treatment patterns and clinical outcomes among patients with metastatic renal cell carcinoma post immune-oncology and vascular endothelial growth factor receptor targeted therapies: A multicenter community oncology-based study. Urol Oncol. 2026 Apr; 44(4):110979.
-
Davis AE, Rhoads S, Wechsler ME. Emerging biologic targets in type 2 and non-type 2 asthma. Curr Opin Pulm Med. 2026 May 01; 32(3):210-219.
-
Carlson DJ, Nichols LM, Moreland LW. Emerging Therapeutics in Rheumatoid Arthritis. Curr Rheumatol Rep. 2026 Jan 31; 28(1):2.
-
Agulnik M, Wilky BA, Thorpe SW, Zuckerman LM. Chondrosarcoma: Clinical behavior, molecular mechanisms, and emerging therapeutic strategies. Crit Rev Oncol Hematol. 2026 Feb; 218:105075.
-
Schreiber AR, Verduzco-Aguirre HC, Giangiuli S, Aranda-Gutierrez A, Roy S, Soto-Perez-de-Celis E. A review of current and emerging therapies in breast cancer: implications for older adults. Expert Rev Clin Pharmacol. 2025 Oct; 18(10):1-16.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|